Jehovana O. Bender

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Navidea Biopharmaceuticals (United States)(Current)

Vanderbilt University Medical Center

Vanderbilt University

Jehovana O. Bender is an author at Navidea Biopharmaceuticals (United States) specializing in oncology, immune checkpoint inhibitors, and immunotherapy.

ORCID

Publications per year

2020–2021

Publications

MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC

Derek A. Franklin, Joe T. Sharick, Paula I. González-Ericsson et al. · JCI Insight · 2020 · 48 citations · Full text

Medicine, Cancer Biology, Oncology +17

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma

Yana G. Najjar, Dustin McCurry, Lin Huang et al. · Clinical Cancer Research · 2021 · 25 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma

Eileen Shiuan, Anupama Reddy, Stephanie O. Dudzinski et al. · Cancers · 2021 · 16 citations · Full text

Medicine, Immunology, Oncology +17

1–3 of 3